◀ Back to NOS1

CPA1 — NOS1

Text-mined interactions from Literome

Finkelberg et al., Acta Physiol (Oxf) 2006 : Amylase release, binding and cyclic adenosine monophosphate ( cAMP ) assays, inositol phosphates ( IPs ) production and nitric oxide synthase (NOS) activity in the presence of cyclopentyl-1,3-dipropylxanthine (CPA) alone or in the presence of different inhibitory drugs were performed
Martin et al., J Pharmacol Exp Ther 1994 : CPA and NECA responses in the presence of endothelium were inhibited by NG-nitro-L-arginine methylester ( L-NAME ), a nitric oxide synthase inhibitor, but not by the cyclooxygenase inhibitor indomethacin or the K+ATP channel antagonist glibenclamide